SUPPORTED STARTUPS
Technology: Drug discovery

Startup Description
Amal Therapeutics SA
Genève 14 - M. Derouazi
Loading...
Development and progression of a new generation of cancer vaccines
Biotechnostics GmbH
Basel - J. Kinter
Loading...
Molecular diagnostic tests for personalized medicine.
BioVersys AG
Basel - M. Gitzinger
Loading...
Bacterial transcriptional regulators, which initiate bacterial defense mechanisms causing drug resistance.
DynaDes AG
Zürich - E. Frugier
Loading...
Dynamic Drug Design deals with the transfer of novel software technology for drug design
EPha.ch AG
Zürich - M. Egbring
Loading...
New service for physicians to search and prescribe drugs.
ExCellness Biotech SA
Lausanne - P. Wipff
Loading...
Novel surfaces for enhanced cell culture.
InSphero AG
Schlieren - W. Moritz
Loading...
3D microtissues for drug discovery and cell therapy.
Mabimmune Cardiology AG
Schlieren - C. Brokopp
Loading...
Mabimmune aims to prevent myocardial infarction and stroke through early diagnosis and targeted treatment.
Ninart Sàrl
R. Koszali
Loading...
New instrument that allows manipulation and multidimensional characterization at the nanoscale of soft samples.
Pan Therapeutics
K. Lundstrom
Loading...
Development of novel anticancer drugs based on viral and non-viral gene delivery.
Phistem Sàrl
Geneva - C. Mas
Loading...
Innovative anti-cancer and stem cell therapies.
SpiroChem AG
Zürich - T. Fessard
Loading...
Spirochem will develop the next generation of molecules for accelerated drug discovery and bring novelty and proven expertise directly from Benchtop to market.
Stemergie Biotechnology SA
Geneva - V. Clément
Loading...
Stemergie Biotechnology SA targets the roots of cancer in developing treatments and diagnostics against brain tumor cancer stem cells (CSCs)
TransCure Biosciences Holding SA
Genève - P. Nef
Loading...
TransCure Biosciences (TCB) is providing humanized mice for pharmaceutical companies

A PHILANTHROPIC INITIATIVE OF A PRIVATE CONSORTIUM

Turning scientific innovation into entrepreneurial activity and job creation is the basis of societal and economical prosperity. In the very early stages, startups bear very high risks that are neither carried by public money nor by private investors. Supporting seed stage startups fills a crucial gap and is therefore purely philanthropic.
Read more about the Foundation of Founders